Fab Antibody Fragment Titer Improvement 

Aug 24, 2026 | Case Studies

Challenge

  • A partner was developing a Fab fragment to quickly neutralize a therapeutic substrate
  • Their E. coli platform generated low Fab titer and meaningful supply was needed for clinical development
  • A cost-effective process required titers >2 g/L
Antibody diagram showing heavy chain, light chain and Fab fragments
pFAB expression plasmid map: 160 Fab expression plasmids screened, including 40 combinations of optimized codons, secretion leaders and RBS sequences

Solution

  • Hundreds of toolbox strains screened at 96-well scale to identify optimized expression of assembled and active Fab
  • Fermentation at 2L scale achieved Fab titers >4 g/L

SCREENING WORKFLOW

  • 800 unique expression strains screened at 96-well scale
  • Down-selected strains assessed at 2L scale for Fab titer under multiple induction conditions (pH, temp; induction OD, time, and inducer concentration)
  • Fab enriched from selected fermentation pastes via affinity chromatography
  • Enriched Fab quality assessed for intact mass
  • >4 g/L of active Fab produced

Key Results

  • 2L fermentations produced assembled Fab over 96-hour induction time
  • Active Fab titers from lysate >4 g/L (SDS-CGE and BLI)
Highest titer strain at 2L, 96 hours post induction, with SDS-CGE and BLI titers, and LC-MS intact mass of enriched Fab
SDS-CGE of 2L fermentation lysate samples at 0, 24 and 48 hours post induction

2L Fermentation Lysate Samples

One strain, one induction condition shown; triplicate analytical samples (0 – 48 hours post induction; SDS-CGE, non-reduced)

#

Return to Resources